All In Biotech

Drug Trial Radar · NCT06795204

Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

A Randomized, Positive and Placebo-Controlled Study to Evaluate the Effects of HSK3486 Administration on Cardiac Repolarization in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Jan 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

48

Actual

Start

Apr 9, 2024

Primary completion

May 19, 2024

Study completion Nov 26, 2024

Sponsor

Sponsor type
Industry
First posted
Jan 27, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To assess the effects of a single IV bolus of HSK3486 single dose on cardiac repolarization (QTc interval of the electrocardiogram, and to evaluate the safety and tolerability of a single IV bolus of HSK3486 in healthy subjects

Conditions

  • Anesthesia; Adverse Effect
  • Cardiac Arrhythmia

Interventions

  • HSK3486Drug

    Study Drug

  • Moxifloxacin HydrochlorideDrug

    Positive Control

  • PlaceboDrug

    Negative Control

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change-from-baseline in QTc IntervalTime frame: From the base line ECG (D-2) to end of the period, up to 24 hours post-dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Gobroad Boren Hospital

    Beijing, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.